Facebook
X
LinkedIn
ForwardMGB APP Grand Rounds and Pharmacology Series 2025-2026 - Archived
Description
This activity provides on-demand archived lectures from the Grand Rounds and Pharmacology Series 2025-2026.. This educational bi-monthly series is designed to provide clinical content that is relevant to multiple disciplines throughout the Mass General Brigham organization. The lectures are designed to provide concise and accurate information that clinicians can use to provide evidence-based care. The lectures have been designed based on feedback from community members.
Course Directors: Erin Schroeder Tombari, NP & Ariel Nowicki PA-C
For questions regarding the registration process, please contact Mass General Brigham Office of Continuing Professional Development at [email protected].
You may print individual certificates throughout the year; your cumulative list of sessions attended is accessible on your transcript.
Target Audience
This activity is intended for APPs (PAs, NPs, pharmacists, MDs) with specialties of any specialty within the MGB network,
Learning Objectives
Upon completion of this activity, participants will be able to:
- Assess the most up to date diagnostic and therapeutic modalities and innovations in care of the patients who are of populations/with conditions discussed in this series
- Understand pharmacologic management of conditions discussed in this series
- Identify subspecialty provider teams to collaborate with regarding medically complex patients
- Be aware of new/up to date practice for conditions discussed in this series
Additional Information
Mass General Brigham
Schedule:
| Date | Subject | Speaker | |
| September 24, 2025 | "Navigating the Research Landscape: A Nurse Scientist's Perspective" | Kathyrn Post, PhD, CNP | |
| October 9, 2025 | Why is that CBC abnormal? – An approach to those pesky blood counts | Dr. David B. Sykes | |
| October 23, 2025 | "Fluoroquinolones: the Great, the Bad and the Ugly" | Ian Zhao, PharmD, BCIDP | |
| November 13, 2025 | "Evidence Based Imaging of the Abdomen and Pelvis", | Dr. Anu Shenoy-Bhangle | |
| November 20, 2025 | "SEXUALLY TRANSMITTED INFECTION UPDATE" | NP Megan Phillips | |
| December 11, 2025 | TBD | ||
| TBD | ||
| TBD | ||
| February 02, 2026 | TBD | ||
| February 26, 2026 | TBD | ||
| March 12, 2026 | TBD | ||
| March 26, 2026 | TBD | ||
| April 09, 2026 | TBD | ||
| April 23, 2026 | TBD | ||
| May 14, 2026 | TBD | ||
| May 28, 2026 | TBD | ||
| June 11, 2026 | TBD | ||
| June 25, 2026 | TBD |
Course Directors
Erin Schroeder, CNP
Nurse Practitioner, Gynecologic Oncology,
Massachusetts General Hospital
Ariel Nowicki, PA-C
Neurosurgery ICU Physician Assistant,
Brigham and Women's Hospital
DISCLOSURE SUMMARY OF RELEVANT FINANCIAL RELATIONSHIPS
MITIGATION STRATEGIES
Mass General Brigham has implemented a process to mitigate relevant financial relationships for this continuing education (CE) activity to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public.
The following planners reported no relevant financial relationship with an ineligible company:
Erin Tombari NP
Ariel Nowicki PA-C
Mike Schontz RPH
ACCREDITATION
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditTM
Mass General Brigham designates this enduring activity for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacy
This activity provides 1 contact hours (1 CEU) of continuing education credit. ACPE Universal Activity Number (UAN): TBD for each activity
Pharmacy Technicians
This activity provides 1 contact hours (1 CEU) of continuing education credit. ACPE Universal Activity Number (UAN): TBD for each activity
*Some sessions offerings carry 1.0 Pharmacotherapeutic contact hours